A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

NCT07387367 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenovirus Infections

Interventions

DRUG: cidofovir
DRUG: Brincidofovir

Sponsor

SymBio Pharmaceuticals